SoylentNews

An Anonymous Coward writes:

Clinical trials of remdesivir, an experimental drug to treat COVID-19, have begun at the University of Nebraska Medical Center [ketv.com] in Omaha. More detail is provided in an article posted by the National Institutes of Health [nih.gov]. The initial trial will involve 400 patients and will be conducted internationally but is beginning in Nebraska. There are currently 15 patients being monitored at UNMC [unmc.edu], 13 of whom have tested positive for COVID-19. According to the daily update from UNMC [nebraskamed.com], all of the 15 patients are now in the National Quarantine Unit, which has 20 beds. Previously, some of the patients had been in the Nebraska Biocontainment Unit [nebraskamed.com], which is the largest facility of its kind in the country and had previously been used to treat ebola patients.

[Note to editors: I recommend leaving in the discussion about the facilities at UNMC and the daily update. The February 25 edition of the daily update mentioned the clinical trial, so there's a good possibility that additional updates will be posted in UNMC's daily update. The additional discussion may help explain why the trial is beginning in Nebraska even though there haven't been any cases that reported here -- everyone at UNMC and those previously quarantined at Camp Ashland were transported here from elsewhere.]

Original Submission